Nestmedic S.A. (WSE:NST)

Poland · Delayed Price · Currency is PLN

0.5000

-0.0400 (-7.41%)

At close: Sep 18, 2026

Market Cap	27.66M -24.5%
Revenue (ttm)	795.19K -25.3%
Net Income	-4.22M
EPS	-0.09
Shares Out	55.33M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	168,547
Open	0.5360
Previous Close	0.5400
Day's Range	0.4950 - 0.5360
52-Week Range	0.4950 - 1.0800
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Nestmedic

Nestmedic S.A., together with its subsidiaries, manufactures telemedicine solutions under the Pregnabit brand. The company offers Pregnabit Pro, a medical device for measuring fetal heart rate, uterine contraction activity, and signaling fetal movements; Pregnabit Cloud, a SaaS system for telemedical CTG devices; and Pregnabit system comprising the mobile CTG device and the medical telemonitoring center service. It sells its products through a distribution network and resellers worldwide. The company was incorporated in 2017 and is headquartere... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2017

Employees 3

Stock Exchange Warsaw Stock Exchange

Ticker Symbol NST

Full Company Profile

Financial Performance

In 2025, Nestmedic's revenue was 846,367, a decrease of -12.67% compared to the previous year's 969,196. Losses were -4.60 million, -14.52% less than in 2024.

Financial Statements